Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation

Arshad,Muhammad; Conzelmann,Charlotte; Riaz,Muhammad  Assad; Noll,Thomas; Gündüz,Dursun

doi:10.3892/ijmm.2018.3828

Inhibition of Cx43 attenuates ERK1/2 activation, enhances the expression of Cav‑1 and suppresses cell proliferation

Authors:
- Muhammad Arshad
- Charlotte Conzelmann
- Muhammad Assad Riaz
- Thomas Noll
- Dursun Gündüz
View Affiliations

Affiliations: Department of Cardiology and Angiology, University Hospital Giessen and Marburg, D‑35392 Giessen, Germany, Department of Radiotherapy, University Hospital Essen, D‑45147 Essen, Germany, Institute of Physiology, Carl Gustav Carus Technical University of Dresden, D‑01307 Dresden, Germany
Published online on: August 16, 2018 https://doi.org/10.3892/ijmm.2018.3828
Pages: 2811-2818

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In addition to being an important component of the gap junction, connexin 43 (Cx43) has been shown to regulate other cellular functions, including cell proliferation. This regulatory role of Cx43 may be important in therapeutic situations, including wound healing or ischemic injuries. Caveolin‑1 (Cav‑1) has been shown to regulate angiogenesis. The aim of the present study was to analyze whether Cx43 counter‑regulates Cav‑1 in controlling the proliferation and migration of endothelial cells. The inhibition of Cx43 with niflumic acid, flufenamic acid and 18‑α‑glycyrrhetinic acid in cultured human umbilical vein endothelial cells resulted in decreased phosphorylation of extracellular signal‑regulated kinase (ERK)1/2 and increased expression of Cav‑1, as shown by western blot analysis. Furthermore, the inhibition of Cx43 resulted in a 50±7% decrease in cell proliferation, determined using a crystal violet assay, a 48±5% decrease in migration, determined using a migration assay, and a 49±6% decrease in endothelial tube formation, determined using a Matrigel assay, compared with the control. Similar results were obtained following specific inhibition of Cx43 by mimetic peptides (Gap26 and Gap27). Inhibition of the mitogen‑activated protein kinase kinase/ERK pathway with PD‑98059 resulted in an increased expression of Cav‑1 and a reduction in the expression of Cx43. Furthermore, cell proliferation, migration and tube formation in endothelial cells were impaired. By contrast, downregulation of the protein expression of Cav‑1 by small interference RNA resulted in increased expression of Cx43 and phosphorylation of ERK1/2. Accordingly, the number of cells in the Cav‑1 treated‑group increased by 35±5% compared with the controls. The data of the present study showed that Cav‑1 suppressed cell proliferation by inhibiting the activity of Cx43, which is upstream of ERK1/2. The downregulation of Cav‑1 protein resulted in loss of the inhibitory activity of Cav‑1 on cell proliferation and led to increased cell proliferation. This counter‑regulatory effect of Cx43 may be of importance in therapeutic angiogenesis.

View Figures

View References

1	Carmeliet P: Angiogenesis in life, disease and medicine. Nature. 438:932–936. 2005. View Article : Google Scholar : PubMed/NCBI
2	Augustin HG: Tubes, branches, and pillars: The many ways of forming a new vasculature. Circ Res. 89:645–647. 2001. View Article : Google Scholar : PubMed/NCBI
3	Larson DM and Haudenschild CC: Junctional transfer in wounded cultures of bovine aortic endothelial cells. Lab Invest. 59:373–379. 1988.PubMed/NCBI
4	Homkajorn B, Sims NR and Muyderman H: Connexin 43 regulates astrocytic migration and proliferation in response to injury. Neurosci Lett. 486:197–201. 2010. View Article : Google Scholar : PubMed/NCBI
5	Walker DL, Vacha SJ, Kirby ML and Lo CW: Connexin43 deficiency causes dysregulation of coronary vasculogenesis. Dev Biol. 284:479–498. 2005. View Article : Google Scholar : PubMed/NCBI
6	Vinken M, Decrock E, De Vuyst E, Ponsaerts R, D'hondt C, Bultynck G, Ceelen L, Vanhaecke T, Leybaert L and Rogiers V: Connexins: Sensors and regulators of cell cycling. Biochim Biophys Acta. 1815:13–25. 2011.
7	Stains JP and Civitelli R: Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell. 16:64–72. 2005. View Article : Google Scholar :
8	Gomes P, Srinivas SP, Vereecke J and Himpens B: ATP-dependent paracrine intercellular communication in cultured bovine corneal endothelial cells. Invest Ophthalmol Vis Sci. 46:104–113. 2005. View Article : Google Scholar
9	Faigle M, Seessle J, Zug S, El Kasmi KC and Eltzschig HK: ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PloS One. 3:e28012008. View Article : Google Scholar : PubMed/NCBI
10	Brisset AC, Isakson BE and Kwak BR: Connexins in vascular physiology and pathology. Antioxid Redox Signal. 11:267–282. 2009. View Article : Google Scholar
11	Goodenough DA, Goliger JA and Paul DL: Connexins, connexons, and intercellular communication. Annu Rev Biochem. 65:475–502. 1996. View Article : Google Scholar : PubMed/NCBI
12	Söhl G and Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res. 62:228–232. 2004. View Article : Google Scholar : PubMed/NCBI
13	Hervé JC and Derangeon M: Gap-junction-mediated cell-to-cell communication. Cell Tissue Res. 352:21–31. 2013. View Article : Google Scholar
14	Bruzzone R, White TW and Paul DL: Connections with connexins: The molecular basis of direct intercellular signaling. Eur J Biochem. 238:1–27. 1996. View Article : Google Scholar : PubMed/NCBI
15	Maeda S and Tsukihara T: Structure of the gap junction channel and its implications for its biological functions. Cell Mol Life Sci. 68:1115–1129. 2011. View Article : Google Scholar
16	Haefliger JA, Nicod P and Meda P: Contribution of connexins to the function of the vascular wall. Cardiovasc Res. 62:345–356. 2004. View Article : Google Scholar : PubMed/NCBI
17	Van Rijen H, van Kempen MJ, Analbers LJ, Rook MB, van Ginneken AC, Gros D and Jongsma HJ: Gap junctions in human umbilical cord endothelial cells contain multiple connexins. Am J Physiol. 272:C117–C130. 1997. View Article : Google Scholar : PubMed/NCBI
18	Wang HH, Kung CI, Tseng YY, Lin YC, Chen CH, Tsai CH and Yeh HI: Activation of endothelial cells to pathological status by down-regulation of connexin43. Cardiovasc Res. 79:509–518. 2008. View Article : Google Scholar : PubMed/NCBI
19	Dhein S, Gaertner C, Georgieff C, Salameh A, Schlegel F and Mohr FW: Effects of isoprenaline on endothelial connexins and angiogenesis in a human endothelial cell culture system. Naunyn Schmiedebergs Arch Pharmacol. 388:101–108. 2015. View Article : Google Scholar
20	Wang HH, Su CH, Wu YJ, Li JY, Tseng YM, Lin YC, Hsieh CL, Tsai CH and Yeh HI: Reduction of connexin43 in human endothelial progenitor cells impairs the angiogenic potential. Angiogenesis. 16:553–560. 2013. View Article : Google Scholar : PubMed/NCBI
21	Xu X, Francis R, Wei CJ, Linask KL and Lo CW: Connexin 43-mediated modulation of polarized cell movement and the directional migration of cardiac neural crest cells. Development. 133:3629–3639. 2006. View Article : Google Scholar : PubMed/NCBI
22	Kardami E, Stoski RM, Doble BW, Yamamoto T, Hertzberg EL and Nagy JI: Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. J Biol Chem. 266:19551–19557. 1991.PubMed/NCBI
23	Gartner C, Ziegelhöffer B, Kostelka M, Stepan H, Mohr FW and Dhein S: Knock-down of endothelial connexins impairs angio-genesis. Pharmacol Res. 65:347–357. 2012. View Article : Google Scholar
24	Polontchouk L, Ebelt B, Jackels M and Dhein S: Chronic effects of endothelin 1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J. 16:87–89. 2002. View Article : Google Scholar
25	Schulz R, Görge PM, Gorbe A, Ferdinandy P, Lampe PD and Leybaert L: Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuropro-tection. Pharmacol Ther. 153:90–106. 2015. View Article : Google Scholar : PubMed/NCBI
26	Bian B, Yu X, Wang Q, Teng T and Nie J: Atorvastatin protects myocardium against ischemia-reperfusion arrhythmia by increasing Connexin 43 expression: A rat model. Eur J Pharmacol. 768:13–20. 2015. View Article : Google Scholar : PubMed/NCBI
27	Strale PO, Clarhaut J, Lamiche C, Cronier L, Mesnil M and Defamie N: Down-regulation of Connexin43 expression reveals the involvement of caveolin-1 containing lipid rafts in human U251 glioblastoma cell invasion. Mol Carcinog. 51:845–860. 2012. View Article : Google Scholar
28	Wang WK, Chen MC, Leong HF, Kuo YL, Kuo CY and Lee CH: Connexin 43 suppresses tumor angiogenesis by down-regulation of vascular endothelial growth factor via hypoxic-induced factor-1α. Int J Mol Sci. 16:439–451. 2014. View Article : Google Scholar : PubMed/NCBI
29	Kwak BR, Mulhaupt F, Veillard N, Gros DB and Mach F: Altered pattern of vascular connexin expression in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 22:225–230. 2002. View Article : Google Scholar : PubMed/NCBI
30	Chadjichristos CE, Derouette JP and Kwak BR: Connexins in atherosclerosis. Adv Cardiol. 42:255–267. 2006. View Article : Google Scholar : PubMed/NCBI
31	Li H, He J, Yu H, Green CR and Chang J: Bioglass promotes wound healing by affecting gap junction connexin 43 mediated endothelial cell behavior. Biomaterials. 84:64–75. 2016. View Article : Google Scholar : PubMed/NCBI
32	Tarzemany R, Jiang G, Jiang JX, Gallant-Behm C, Wiebe C, Hart DA, Larjava H and Häkkinen L: Connexin 43 regulates the expression of wound healing-related genes in human gingival and skin fibroblasts. Exp Cell Res. 367:150–161. 2018. View Article : Google Scholar : PubMed/NCBI
33	Fang K, Fu W, Beardsley AR, Sun X, Lisanti MP and Liu J: Overexpression of caveolin-1 inhibits endothelial cell proliferation by arresting the cell cycle at G₀/G₁ phase. Cell Cycle. 6:199–204. 2007. View Article : Google Scholar : PubMed/NCBI
34	Lin MI, Yu J, Murata T and Sessa WC: Caveolin-1-deficient mice have increased tumor microvascular permeability, angiogenesis, and growth. Cancer Res. 67:2849–2856. 2007. View Article : Google Scholar : PubMed/NCBI
35	Sotkis A, Wang XG, Yasumura T, Peracchia LL, Persechini A, Rash JE and Peracchia C: Calmodulin colocalizes with connexins and plays a direct role in gap junction channel gating. Cell Commun Adhes. 8:277–281. 2001. View Article : Google Scholar
36	Giepmans BN, Verlaan I, Hengeveld T, Janssen H, Calafat J, Falk MM and Moolenaar WH: Gap junction protein connexin-43 interacts directly with microtubules. Curr Biol. 11:1364–1368. 2001. View Article : Google Scholar : PubMed/NCBI
37	Schubert AL, Schubert W, Spray DC and Lisanti MP: Connexin family members target to lipid raft domains and interact with caveolin-1. Biochemistry. 41:5754–5764. 2002. View Article : Google Scholar : PubMed/NCBI
38	Langlois S, Cowan KN, Shao Q, Cowan BJ and Laird DW: Caveolin-1 and -2 interact with connexin43 and regulate gap junctional intercellular communication in keratinocytes. Mol Biol Cell. 19:912–928. 2008. View Article : Google Scholar :
39	Razani B, Schlegel A, Liu J and Lisanti MP: Caveolin-1, a putative tumour suppressor gene. Biochem Soc Trans. 29:494–499. 2001. View Article : Google Scholar : PubMed/NCBI
40	Galbiati F, Volonté D, Liu J, Capozza F, Frank PG, Zhu L, Pestell RG and Lisanti MP: Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell. 12:2229–2244. 2001. View Article : Google Scholar : PubMed/NCBI
41	Hartel FV, Holl M, Arshad M, Aslam M, Gündüz D, Weyand M, Micoogullari M, Abdallah Y, Piper HM and Noll T: Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells. Am J Physiol Cell Physiol. 298:C1501–C1509. 2010. View Article : Google Scholar : PubMed/NCBI
42	World Medical Association Declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc Res. 35:2–3. 1997.
43	Zhao Y, Yu L, Xu S, Qiu F, Fan Y and Fu G: Down-regulation of connexin43 gap junction by serum deprivation in human endo-thelial cells was improved by (-)-Epigallocatechin gallate via ERK MAP kinase pathway. Biochem Biophys Res Commun. 404:217–222. 2011. View Article : Google Scholar
44	Li B, Jia S, Yue T, Yang L, Huang C, Verkhratsky A and Peng L: Biphasic regulation of Caveolin-1 gene expression by fluoxetine in astrocytes: Opposite effects of PI3K/AKT and MAPK/ERK signaling pathways on c-fos. Front Cell Neurosci. 11:3352017. View Article : Google Scholar : PubMed/NCBI
45	Braet K, Vandamme W, Martin PE, Evans WH and Leybaert L: Photoliberating inositol-1,4,5-trisphosphate triggers ATP release that is blocked by the connexin mimetic peptide gap 26. Cell Calcium. 33:37–48. 2003. View Article : Google Scholar : PubMed/NCBI
46	Leybaert L, Braet K, Vandamme W, Cabooter L, Martin PE and Evans WH: Connexin channels, connexin mimetic peptides and ATP release. Cell Commun Adhes. 10:251–257. 2003. View Article : Google Scholar : PubMed/NCBI
47	Nandigama R, Padmasekar M, Wartenberg M and Sauer H: Feed forward cycle of hypotonic stress-induced ATP release, puri-nergic receptor activation, and growth stimulation of prostate cancer cells. J Biol Chem. 281:5686–5693. 2006. View Article : Google Scholar
48	Galbiati F, Volonte D, Engelman JA, Watanabe G, Burk R, Pestell RG and Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperac-tivate the p42/44 MAP kinase cascade. EMBO J. 17:6633–6648. 1998. View Article : Google Scholar : PubMed/NCBI
49	Park H, Go YM, St John PL, Maland MC, Lisanti MP, Abrahamson DR and Jo H: Plasma membrane cholesterol is a key molecule in shear stress-dependent activation of extracellular signal-regulated kinase. J Biol Chem. 273:32304–32311. 1998. View Article : Google Scholar : PubMed/NCBI
50	Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS and Lisanti MP: Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 428:205–211. 1998. View Article : Google Scholar : PubMed/NCBI
51	Chambard JC, Lefloch R, Pouysségur J and Lenormand P: ERK implication in cell cycle regulation. Biochim Biophys Acta. 1773:1299–1310. 2007. View Article : Google Scholar